Drug class in one race
NLRP3 inflammasome drugs for Obesity
2 tracked NLRP3 inflammasome drugs in the Obesity race. The class explanation lives on the NLRP3 inflammasome page; the full indication pipeline across every mechanism is on the Obesity page.
2 Phase 2
Head-to-head evidence: NT-0796 vs VTX3232